| 000 | 01534 a2200421 4500 | ||
|---|---|---|---|
| 005 | 20250511131946.0 | ||
| 264 | 0 | _c19770425 | |
| 008 | 197704s 0 0 eng d | ||
| 022 | _a0008-543X | ||
| 024 | 7 |
_a10.1002/1097-0142(197702)39:2+<806::aid-cncr2820390715>3.0.co;2-x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aTefft, M | |
| 245 | 0 | 0 |
_aRadiation in bone sarcomas: a re-evaluation in the era of intensive systemic chemotherapy. _h[electronic resource] |
| 260 |
_bCancer _cFeb 1977 |
||
| 300 |
_a806-16 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article | ||
| 650 | 0 | 4 |
_aBone Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aChild |
| 650 | 0 | 4 |
_aCyclophosphamide _xtherapeutic use |
| 650 | 0 | 4 |
_aDactinomycin _xtherapeutic use |
| 650 | 0 | 4 |
_aDoxorubicin _xtherapeutic use |
| 650 | 0 | 4 | _aDrug Therapy, Combination |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLeucovorin _xtherapeutic use |
| 650 | 0 | 4 |
_aLung Neoplasms _xradiotherapy |
| 650 | 0 | 4 |
_aMethotrexate _xtherapeutic use |
| 650 | 0 | 4 | _aNeoplasm Metastasis |
| 650 | 0 | 4 |
_aOsteosarcoma _xdrug therapy |
| 650 | 0 | 4 | _aRadiation Tolerance |
| 650 | 0 | 4 | _aRadiotherapy Dosage |
| 650 | 0 | 4 | _aRadiotherapy, High-Energy |
| 650 | 0 | 4 |
_aSarcoma, Ewing _xdrug therapy |
| 650 | 0 | 4 |
_aVincristine _xtherapeutic use |
| 700 | 1 | _aChabora, B M | |
| 700 | 1 | _aRosen, G | |
| 773 | 0 |
_tCancer _gvol. 39 _gno. 2 Suppl _gp. 806-16 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1002/1097-0142(197702)39:2+<806::aid-cncr2820390715>3.0.co;2-x _zAvailable from publisher's website |
| 999 |
_c422896 _d422896 |
||